DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/14070
Title: To estimate effective antiamyloidogenic property of melatonin and fisetin and their actions to destabilize amyloid fibrils
Authors: Hossein Aarabi, Mohammad
Mehdi Mirhashemi, Seyyed
Keywords: Amylin
Diabetes Mellitus
Melatonin
Fisetin
Amylin fibrils
Issue Date: 10-Sep-2017
Publisher: Karachi: Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi
Citation: Aarabi, M. H., & Mirhashemi, S. M. (2017). To estimate effective antiamyloidogenic property of melatonin and fisetin and their actions to destabilize amyloid fibrils. Pak J Pharm Sci, 30(5), 1589-1593.
Abstract: Aggregating of amylin as pancreatic deposition is connected with pancreas degeneration in type 2 diabetes mellitus. Suppression of the amylin accumulation and so instability of the pre-formed pancreatic β-amyloid, may be attractive curative goal for mediation of diabetes mellitus. Fluorimetric assay by Thioflavin-T was utilized for investigating the properties of melatonin and fisetin on the generation and instability of β-amyloid near to physiological conditions. The results showed that after 168 hours incubation by shaker incubator in 37o C, melatonin at 10µM and 40 µM repressed amylin amyloid formation by 20.1% and 27.5% respectively (p<0.05) and the similar values of fisetin inhibited the formation of β-sheet structure by 16.5% and 23.2% respectively (p<0.05).The obtained data also confirmed that amyloidal sheet opening was induced by elatonin and fisetin significantly (p<0.05). It may be concluded that islet amyloid cytotoxicity to β-cells may be reduced by melatonin and fisetin, and they should be important constituents of new drugs for diabetes mellitus reatment.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/14070
ISSN: 1011-601X
Appears in Collections:No.5 September, 2017

Files in This Item:
File Description SizeFormat 
Paper-10.htm132 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.